Clinical Trials Logo

Overweight clinical trials

View clinical trials related to Overweight.

Filter by:

NCT ID: NCT04516252 Recruiting - Clinical trials for Overweight and Obesity

Enhancing BodyWorks: A Canine Health Literacy Module

BW
Start date: February 27, 2021
Phase: N/A
Study type: Interventional

Dog ownership can serve as a vehicle for large-scale multi-level public health interventions, especially for pediatric overweight and obesity, due to dogs' unique place in children and adolescents' social networks.This study develops and tests a novel approach to design a Canine Health-Literacy module to enhance a Comprehensive Family Lifestyle Intervention BodyWorks, for dog-owning adolescents who have been diagnosed with overweight or obesity, and their parents. The results are anticipated to make an important step towards addressing the overweight and obesity epidemic among both people and companion dogs in the U.S.

NCT ID: NCT04496895 Recruiting - Overweight Clinical Trials

The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults

Start date: November 12, 2022
Phase: N/A
Study type: Interventional

To assess whether orange peel fermentation has the effect of reducing body fat in adults

NCT ID: NCT04487743 Recruiting - Obesity Clinical Trials

Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities

Start date: May 9, 2020
Phase: Phase 3
Study type: Interventional

We performed a multicenter, randomized, double-blind, placebo-controlled 28-week trial. 300 non-diabetic obese subjects or overweight subjects with co-morbidities were randomly assigned. Eligible participants were randomized 2:1 to once-daily subcutaneous injections of either liraglutide or placebo. The primary outcome is to investigate the safety, tolerability from baseline to end of treatment.

NCT ID: NCT04469400 Recruiting - Clinical trials for Overweight and Obesity

Lifestyle Intervention for Patients With Impaired Glucose Regulation

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Impaired glucose regulation (IGR) is closely related to overweight/obesity. By studying different dietary patterns (energy-limited diet vs. low-carbohydrate diet) and intensive lifestyle interventions combined with blood glucose monitoring, glucose regulation of overweight/obesity is affected. To improve the blood glucose and related metabolic indexes of patients with impaired (IGR), establish 1-2 clinical intervention programs for impaired glucose regulation.

NCT ID: NCT04465721 Recruiting - Clinical trials for Overweight and Obesity

TREAT to Improve Cardiometabolic Health

NY-TREAT
Start date: June 14, 2021
Phase: N/A
Study type: Interventional

Over half of American adults have overweight or obesity and are at high risk of developing type 2 diabetes and cardiovascular diseases. Although caloric restriction has many health benefits, it is difficult to sustain overtime for most people. Time restricted eating (TRE), a novel type of intermittent fasting, facilitates adherence to the intervention and results in weight loss and improvement of metabolism. The investigators propose to examine the efficacy of self-monitoring and TRE (10-h/d) vs. self-monitoring and habitual prolonged eating duration (HABIT) (13 hours/d) on weight loss and body composition, metabolic function and circadian biology, in metabolically unhealthy adults aged 50 to 75 y old, with overweight or obesity. The investigators hypothesize that TRE, compared to habitual long duration of eating, will decrease cardiovascular risk burden.

NCT ID: NCT04451616 Recruiting - Obesity Clinical Trials

Assessment of Progranulin and FAM19A5 Protein Blood Levels in Metabolic Syndrome

PROG-FAM
Start date: July 3, 2020
Phase:
Study type: Observational [Patient Registry]

The main objective of the study is to assess the serum levels of progranulin and FAM19A5 protein in adults with metabolic syndrome.

NCT ID: NCT04434534 Recruiting - Clinical trials for Overweight and Obesity

Effect of Açaí Juçara Consumption on Endothelial Function and Arterial Stiffness

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates the consumption of Açaí Juçara pulp in endothelial function and arterial stiffness in overwheight and obese individuals. Half of participants will receive a hipocaloric diet and two Açaí Juçara pulps for daily consumption, while the other half will receive just a hipocaloric diet.

NCT ID: NCT04411511 Recruiting - Covid-19 Clinical Trials

COVID-19, Obesity and Lifestyle in Children

COLC
Start date: May 6, 2020
Phase:
Study type: Observational

This study aims to evaluate the impact of the COVID-19 pandemic and its measures on lifestyle in Dutch children between 4 - 18 years.

NCT ID: NCT04351672 Recruiting - Clinical trials for Overweight and Obesity

Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans

ChronoFast
Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This human dietary intervention study with a cross-over design aims to compare the effects of two isocaloric diets - early time-restricted feeding (TRF) vs. late TRF - on glycemic control and lipid metabolism in overweight and obese women.

NCT ID: NCT04307797 Recruiting - Obesity Clinical Trials

Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes

COCONUT
Start date: January 18, 2022
Phase: Phase 4
Study type: Interventional

The study seeks to explore the cardiovascular effects of co-agonism at the glucagon and (glucagon-like peptide-1) GLP-1 receptor. Glucagon and exenatide will be intravenously infused into participants with type 2 diabetes (T2DM). Overall, the aim of the study is to further the investigator's understanding on the role these endogenous substances have on normal cardiac physiology, myocardial energetics and myocardial glucose uptake through a series of PET and MRI imaging studies